Related Experiment Video

Updated: Jun 18, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

A new generation of studies of human papillomavirus DNA testing in cervical cancer screening

Eduardo L Franco

    Journal of the National Cancer Institute
    |November 12, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
    06:57

    Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

    Published on: June 14, 2019

    Related Experiment Videos

    Last Updated: Jun 18, 2026

    RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
    10:26

    RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

    Published on: March 11, 2014

    Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
    06:57

    Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

    Published on: June 14, 2019

    Related Concept Videos

    Next-generation Sequencing03:00

    Next-generation Sequencing

    The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
    Next-Generation Sequencing Methods
    Although all next-generation methods use different technologies, they all share a set of standard features.

    Articles linked to this work by shared authors, journal, and citation graph.

    Epstein-Barr virus-attributable cancers among children and adolescents in Europe and North America: a meta-analysis.

    Journal of the National Cancer Institute·2026

    The need to change cervical cancer screening in the post-human papillomavirus vaccination era: the interplay between disease prevalence and risk, test characteristics, and efficiency of screening programs.

    Journal of the National Cancer Institute. Monographs·2026

    Time to Diagnosis Among Children and Adolescents With Cancer in Québec, Canada: A Population-Based Study.

    Pediatric blood & cancer·2026

    The Association Between Human Papillomavirus and Prostate Cancer: A Systematic Review and Meta-Analysis.

    International journal of cancer·2026

    HPV Testing Versus Cytology for Cervical Cancer Screening Among Women 50 Years and Older: Evidence From the HPV FOCAL Randomized Controlled Trial.

    International journal of cancer·2026

    Impact of switching from a quadrivalent to a nonavalent HPV vaccine on HPV infections and cervical cancer in Colombia: a mathematical modelling study.

    Lancet regional health. Americas·2026

    Novel framework for the validation of intermediate clinical endpoints in oncology real-world data.

    Journal of the National Cancer Institute·2026

    Time trends of human papillomavirus-attributable head and neck cancers: the BROADEN study.

    Journal of the National Cancer Institute·2026

    Cardio-protection and monitoring for early phase clinical trials: Recommendations from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

    Journal of the National Cancer Institute·2026

    Colonoscopy screening outcomes in Lynch syndrome and differential colorectal cancer paths among MLH1/MSH2 carriers.

    Journal of the National Cancer Institute·2026

    Identification of prediagnostic proteomic biomarkers for colon and rectal cancer in 3 prospective cohorts.

    Journal of the National Cancer Institute·2026

    Claims-based frailty, dual eligibility, and potential unmet home-health needs in older breast cancer survivors.

    Journal of the National Cancer Institute·2026

    Screening for Early Endometriosis Detection (SEED): Co-development of a Symptom-Based Screening Measure for Canadian Young Adults in Primary Care.

    Canadian journal of pain = Revue canadienne de la douleur·2026

    Fibrinogen Alpha Chain (FGA) Associates With Epithelial-Mesenchymal Transition, Stemness, and the USP-Catenin Complex in Colorectal Cancer.

    Stem cells international·2026

    Multimodal biomarkers for early detection and immunotherapy assessment in hepatocellular carcinoma: integrating liquid biopsy, AI-based imaging and tumor immune profiling.

    Frontiers in genetics·2026

    Spatiotemporal Analysis of Molecular Continuity in Pathogenesis of Squamous Cell Carcinoma: From Normal Epithelium to Precancerous Lesions and Carcinoma.

    Cancer communications (London, England)·2026

    Histopathological Spectrum in FIT-Positive Patients With Abnormal Colonoscopy Findings at a Tertiary Medical Center in Lebanon: A Retrospective Observational Study.

    Health science reports·2026

    How AI-based techniques for brain tumour diagnosis can address data variability.

    Frontiers in bioinformatics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us